CA1334936C - Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration - Google Patents
Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administrationInfo
- Publication number
- CA1334936C CA1334936C CA000595327A CA595327A CA1334936C CA 1334936 C CA1334936 C CA 1334936C CA 000595327 A CA000595327 A CA 000595327A CA 595327 A CA595327 A CA 595327A CA 1334936 C CA1334936 C CA 1334936C
- Authority
- CA
- Canada
- Prior art keywords
- homeopathic
- mixture
- herb
- magnetized
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 39
- 230000001632 homeopathic effect Effects 0.000 title abstract description 129
- 238000002360 preparation method Methods 0.000 title description 3
- 239000008194 pharmaceutical composition Substances 0.000 title description 2
- 238000001467 acupuncture Methods 0.000 claims abstract description 51
- 239000000203 mixture Substances 0.000 claims abstract description 46
- 239000000126 substance Substances 0.000 claims abstract description 33
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 19
- 241000282414 Homo sapiens Species 0.000 claims abstract description 14
- 230000000699 topical effect Effects 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- 230000001717 pathogenic effect Effects 0.000 claims abstract description 5
- 239000012676 herbal extract Substances 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000006187 pill Substances 0.000 claims description 19
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 83
- 238000011282 treatment Methods 0.000 abstract description 49
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 229940098465 tincture Drugs 0.000 description 35
- 238000009472 formulation Methods 0.000 description 22
- 239000004222 ferrous gluconate Substances 0.000 description 20
- 229960001645 ferrous gluconate Drugs 0.000 description 20
- 235000013924 ferrous gluconate Nutrition 0.000 description 20
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 20
- 239000006186 oral dosage form Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 239000002552 dosage form Substances 0.000 description 14
- 239000000284 extract Substances 0.000 description 14
- 239000012895 dilution Substances 0.000 description 10
- 238000010790 dilution Methods 0.000 description 10
- 235000008216 herbs Nutrition 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- 102000009025 Endorphins Human genes 0.000 description 4
- 108010049140 Endorphins Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000005672 electromagnetic field Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000000472 traumatic effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 235000015250 liver sausages Nutrition 0.000 description 3
- XYSQXZCMOLNHOI-UHFFFAOYSA-N s-[2-[[4-(acetylsulfamoyl)phenyl]carbamoyl]phenyl] 5-pyridin-1-ium-1-ylpentanethioate;bromide Chemical compound [Br-].C1=CC(S(=O)(=O)NC(=O)C)=CC=C1NC(=O)C1=CC=CC=C1SC(=O)CCCC[N+]1=CC=CC=C1 XYSQXZCMOLNHOI-UHFFFAOYSA-N 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001673966 Magnolia officinalis Species 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000000617 arm Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 235000011475 lollipops Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000013160 medical therapy Methods 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 239000007935 oral tablet Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- SVYNLIRHKQCPNE-UHFFFAOYSA-N 3,4-dihydro-1h-isoquinolin-2-ium-2-ylidenemethanediamine;hydrogen sulfate Chemical compound OS(O)(=O)=O.C1=CC=C2CN(C(=N)N)CCC2=C1 SVYNLIRHKQCPNE-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 244000284152 Carapichea ipecacuanha Species 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 240000003791 Citrus myrtifolia Species 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000283715 Damaliscus lunatus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 244000055664 Dichroa febrifuga Species 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 241000224432 Entamoeba histolytica Species 0.000 description 1
- 241001465251 Ephedra sinica Species 0.000 description 1
- 241001547070 Eriodes Species 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000224467 Giardia intestinalis Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 241000556074 Grindelia camporum Species 0.000 description 1
- 241001530884 Gynura segetum Species 0.000 description 1
- 208000001688 Herpes Genitalis Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 235000003470 Ilex asprella Nutrition 0.000 description 1
- 241001100541 Ilex asprella Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001495448 Impatiens <genus> Species 0.000 description 1
- 241000726306 Irus Species 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 241000366182 Melaleuca alternifolia Species 0.000 description 1
- 240000008821 Menyanthes trifoliata Species 0.000 description 1
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 1
- 206010027951 Mood swings Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010057852 Nicotine dependence Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000001382 Ornithogalum umbellatum Species 0.000 description 1
- 235000016547 Ornithogalum umbellatum Nutrition 0.000 description 1
- 240000001076 Osbeckia chinensis Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000004659 Picrasma quassioides Species 0.000 description 1
- 235000010913 Picrasma quassioides Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000123887 Pulsatilla chinensis Species 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 244000097577 Rhus javanica Species 0.000 description 1
- 235000010889 Rhus javanica Nutrition 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000257673 Strobilanthes cusia Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000985696 Tecoma Species 0.000 description 1
- 208000025569 Tobacco Use disease Diseases 0.000 description 1
- 241000159243 Toxicodendron radicans Species 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 244000248021 Vitex negundo Species 0.000 description 1
- 235000010363 Vitex negundo Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- SMDHCQAYESWHAE-UHFFFAOYSA-N benfluralin Chemical compound CCCCN(CC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O SMDHCQAYESWHAE-UHFFFAOYSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 235000019788 craving Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 108010024043 drainin Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940007078 entamoeba histolytica Drugs 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000004946 genital herpes Diseases 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229940085435 giardia lamblia Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000009442 healing mechanism Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229930190166 impatien Natural products 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000028756 lack of coordination Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- SETMGIIITGNLAS-UHFFFAOYSA-N spizofurone Chemical compound O=C1C2=CC(C(=O)C)=CC=C2OC21CC2 SETMGIIITGNLAS-UHFFFAOYSA-N 0.000 description 1
- 229950001870 spizofurone Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 235000019505 tobacco product Nutrition 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000009685 tusanqi Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17673188A | 1988-04-01 | 1988-04-01 | |
| US176,731 | 1988-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1334936C true CA1334936C (en) | 1995-03-28 |
Family
ID=22645606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000595327A Expired - Fee Related CA1334936C (en) | 1988-04-01 | 1989-03-31 | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0409893A4 (en)van) |
| JP (1) | JPH03503648A (en)van) |
| AU (1) | AU632481B2 (en)van) |
| CA (1) | CA1334936C (en)van) |
| IN (1) | IN169075B (en)van) |
| NZ (1) | NZ228593A (en)van) |
| WO (1) | WO1989009049A1 (en)van) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1243476B (it) * | 1990-08-01 | 1994-06-15 | Enza Ciccolo | Metodo per il riconoscimento di attivita' frequenziali e bioenergetiche in acque e loro uso |
| FR2675385B1 (fr) * | 1991-04-18 | 1993-07-23 | Boulay Maurice | Produit calmant et revitalisant contenant de la poudre d'aimant. |
| WO1993003712A1 (en) * | 1991-08-20 | 1993-03-04 | Daniel Mcnair | A device for the administration of homeopathic compositions |
| IT1290779B1 (it) * | 1995-06-26 | 1998-12-10 | Antonio Sacchetti | Procedimento per il potenziamento delle attivita' terapeutiche di sostanze naturali (vitamine, minerali, erbe, fitopreparati, alimenti) |
| WO2002066041A1 (en) * | 2001-02-23 | 2002-08-29 | Herbal Detox Therapy Aps | Natural composition |
| US6552035B2 (en) * | 2001-09-13 | 2003-04-22 | Hwa-Mok Park | Composition for inducing smoking cessation comprising alkaloids from Radix ipecauanhae |
| US6844014B1 (en) | 2002-07-22 | 2005-01-18 | Stephen Rafkin | Herbal healing lotion for veterinary use |
| DE202014103194U1 (de) * | 2014-07-11 | 2014-07-29 | Marianna Gross | Homöopathisches Mittel zur Raucherentwöhnung |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2671451A (en) * | 1952-06-16 | 1954-03-09 | Stephen J Bolger | Remedial pill |
| DE1467974A1 (de) * | 1964-06-08 | 1969-01-23 | Tsukamoto Kenkichi | Verfahren zur Verbesserung der Wirksamkeit von Eisenpraeparaten und Vorrichtung zur Durchfuehrung des Verfahrens |
| DE1492136A1 (de) * | 1965-01-30 | 1969-09-18 | Seuss Dr Med Willy | Einrichtung zur therapeutischen Beeinflussung des menschlichen Koerpers durch statische Elektrizitaet |
| DE1692771A1 (de) * | 1968-02-24 | 1972-01-05 | Willy Dr Med Seuss | Verfahren zur Zubereitung innerlich oder aeusserlich anwendbarer physiologisch wirksamer Stoffe und danach hergestellte Mittel |
| BE759692A (fr) * | 1969-12-23 | 1971-05-17 | Soliman Henri | Medicament mineralo-vegetal |
| FR2258839A1 (en) * | 1974-01-28 | 1975-08-22 | Sitbon Georges | Colloidal therapeutic iron solutions - treatment for cancer, leukaemia, arterial and cardiac disorders, neurological disorders, anti-radiation agents, etc. |
| SE431214B (sv) * | 1977-06-02 | 1984-01-23 | Klaus H Mosbach | Sett att framstella magnetiska polymerpartiklar som berare av en foretredesvis biologiskt aktiv substans |
| US4357259A (en) * | 1977-08-01 | 1982-11-02 | Northwestern University | Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres |
| JPS576041A (en) * | 1980-02-25 | 1982-01-12 | Kimikiyo Harada | Folding formation type metal stud |
| FR2477022A1 (fr) * | 1980-03-03 | 1981-09-04 | Flux Yang Ste Civile | Dispositif pour l'application localisee d'un champ magnetique sur un objet, notamment un etre vivant |
| EP0093757A1 (en) * | 1981-11-12 | 1983-11-16 | Ulf SCHRÖDER | Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof |
| JPS5945378A (ja) * | 1982-09-09 | 1984-03-14 | Toyobo Co Ltd | 粘着材料 |
| JPS6032716A (ja) * | 1983-07-29 | 1985-02-19 | Yasuo Sawada | 特殊脂肪酸と磁化鉄粉含有の殺菌薬と病体の恢復力を速める薬の製造方法 |
| JPS61115015A (ja) * | 1984-11-08 | 1986-06-02 | Shimazaki Shiyubiyou Kk | 帯磁化粧品 |
| EP0208362A1 (en) * | 1985-06-28 | 1987-01-14 | The Procter & Gamble Company | Dietary supplements containing iron and enterically coated calcium |
| JPS62175419A (ja) * | 1986-01-25 | 1987-08-01 | Tomoji Tanaka | 人工温泉浴剤 |
| DE3634121A1 (de) * | 1986-05-09 | 1987-11-12 | Otto Kausch | Verfahren und einrichtung zur verbesserung der wirkungen fluessiger oder pastoeser praeparate |
| JPS63159313A (ja) * | 1986-12-24 | 1988-07-02 | Olympus Optical Co Ltd | 治療用薬剤 |
-
1989
- 1989-03-31 CA CA000595327A patent/CA1334936C/en not_active Expired - Fee Related
- 1989-04-03 NZ NZ228593A patent/NZ228593A/en unknown
- 1989-04-03 JP JP1504757A patent/JPH03503648A/ja active Pending
- 1989-04-03 AU AU34260/89A patent/AU632481B2/en not_active Ceased
- 1989-04-03 WO PCT/US1989/001400 patent/WO1989009049A1/en active Application Filing
- 1989-04-03 EP EP19890904967 patent/EP0409893A4/en not_active Withdrawn
- 1989-04-05 IN IN258/CAL/89A patent/IN169075B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0409893A1 (en) | 1991-01-30 |
| AU3426089A (en) | 1989-10-16 |
| IN169075B (en)van) | 1991-08-31 |
| JPH03503648A (ja) | 1991-08-15 |
| AU632481B2 (en) | 1993-01-07 |
| NZ228593A (en) | 1992-07-28 |
| WO1989009049A1 (en) | 1989-10-05 |
| EP0409893A4 (en) | 1991-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5162037A (en) | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration | |
| AU723812B2 (en) | Medicinal preparation and a method of medicinal action on human organism | |
| CN101417013A (zh) | 一种用于风湿骨痛的中药巴布剂及其制备方法 | |
| CA1334936C (en) | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration | |
| TWI352597B (en) | Composition having effect of moxibustion and press | |
| CN105030901A (zh) | 治疗皮肤病的中药组合物及其使用方法 | |
| RU2346696C2 (ru) | Способ стимуляции иммунной системы человека активированным минералом, содержащим платиноиды, способ активации минерала и состав, обладающий свойствами стимуляции иммунной системы | |
| RU2040271C1 (ru) | Средство "наркодел" для лечения алкогольной зависимости | |
| CN103285162A (zh) | 用于补肾壮阳的中药组合物及其制备方法 | |
| CN1049454A (zh) | 男用润滑剂的制备方法 | |
| CN101361868B (zh) | 一种治疗风湿的中药组合物 | |
| CN106177874A (zh) | 一种治疗咳喘的药物贴片及其制备方法 | |
| Abascal et al. | Herbal treatments for pandemic influenza: learning from the eclectics' experience | |
| CN1219431A (zh) | 火功舒通宁保健袋 | |
| CN104257719A (zh) | 消肿散结的中西药多用途软膏及其制备方法 | |
| CN102552440A (zh) | 一种平喘消炎药物及其制备方法和用途 | |
| CN1080563C (zh) | 向日葵秆芯作为制备治疗癌症的药剂的用途 | |
| Biddle | Materia medica | |
| CN113491735A (zh) | 一种抗失眠穴位贴 | |
| CN1109770A (zh) | 冰蟾消肿止痛膏及其中药配方和制备方法 | |
| CN1148200C (zh) | 一种治癌的中草药 | |
| CN1092976C (zh) | 苦荬菜在制备治疗结核病药物方面的用途 | |
| CN113813316A (zh) | 一种治疗阳痿的中西药复合方 | |
| CN102274469A (zh) | 一种预防和治疗铅中毒的组合物及其制备方法 | |
| CN101912398B (zh) | 治疗尿路感染的药物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |